Note 11 - Loss per share (Tables)

6 Months Ended

Sep. 30, 2023

Notes To Financial Statements [Abstract]

Schedule of diluted net loss per share attributable to common shareholders

The Corporation excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:

	September 30, 2023	September 30, 2022
Options outstanding	561,365	740,974
September 2023 US private offering pre-funded warrants	2,106,853	—
September 2023 US private offering warrants	2,536,391	—
May 2018 public offering warrants	—	137,370
December 2017 public offering warrants	—	147,354
December 2017 public offering broker warrants	—	5,399